Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway

BACKGROUND: Diabetic nephropathy (DN) is the leading cause of end-stage renal failure, contributing to severe morbidity and mortality in diabetic patients. Berberine (BBR) has been well characterized to exert renoprotective effects in DN progression. However, the action mechanism of BBR in DN remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Liping, Han, Jiakai, Yuan, Rongrong, Xue, Lei, Pang, Wuyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878418/
https://www.ncbi.nlm.nih.gov/pubmed/29604956
http://dx.doi.org/10.1186/s40659-018-0157-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878418/
https://www.ncbi.nlm.nih.gov/pubmed/29604956
http://dx.doi.org/10.1186/s40659-018-0157-8

Ejemplares similares